Fig. 3: Impact of the multistage AI-driven workflow on breast cancer screening outcomes.
From: Equitable impact of an AI-driven breast cancer screening workflow in real-world US-wide deployment
CDR, RR and PPV1 in the standard of care versus the multistage AI-driven workflow cohort across the whole population, in individual race and ethnicity subpopulations, and divided up by breast density. See Table 2 for numerator and denominator values. Data are presented as the unadjusted rate, and lines are the 95% Agresti and Coull CIs. All standard of care (grey) and multistage AI-driven workflow (purple) paired comparisons indicated with an asterisk are significant (*P < 0.05) under an unadjusted one-sided chi-squared comparison (see Table 2 for exact P values). See Supplementary Table 1 for details of CDR, RR and PPV1 and comparisons for other demographic groups.
